Advertisement

Topics

ACHN Soars On PNH Data, ACAD Abuzz, ALDR On Track, Zealand To Debut On Nasdaq

04:56 EDT 9 Aug 2017 | RTTNews

Today's Daily Dose brings you news about Achillion's phase II trial results of ACH-4471 in paroxysmal nocturnal hemoglobinuria; ACADIA's improving financials; Alder's near-term catalysts; Navidea's progress in its pipeline and Theravence's anticipated milestones.

Original Article: ACHN Soars On PNH Data, ACAD Abuzz, ALDR On Track, Zealand To Debut On Nasdaq

NEXT ARTICLE

More From BioPortfolio on "ACHN Soars On PNH Data, ACAD Abuzz, ALDR On Track, Zealand To Debut On Nasdaq"

Quick Search
Advertisement
 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...